A detailed history of Advisory Services Network, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Advisory Services Network, LLC holds 17,686 shares of CRSP stock, worth $716,813. This represents 0.02% of its overall portfolio holdings.

Number of Shares
17,686
Previous 17,686 -0.0%
Holding current value
$716,813
Previous $955,000 12.98%
% of portfolio
0.02%
Previous 0.02%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$51.17 - $68.18 $5,731 - $7,636
112 Added 0.64%
17,686 $955,000
Q1 2024

May 06, 2024

SELL
$60.67 - $89.12 $6,067 - $8,912
-100 Reduced 0.57%
17,574 $1.2 Million
Q4 2023

Feb 09, 2024

BUY
$38.62 - $72.18 $148,841 - $278,181
3,854 Added 27.89%
17,674 $1.11 Million
Q3 2023

Nov 14, 2023

SELL
$45.39 - $59.0 $32,045 - $41,654
-706 Reduced 4.86%
13,820 $627,000
Q2 2023

Aug 09, 2023

BUY
$43.47 - $67.77 $7,389 - $11,520
170 Added 1.18%
14,526 $815,000
Q1 2023

May 17, 2023

BUY
$41.0 - $56.12 $488,187 - $668,220
11,907 Added 486.2%
14,356 $649,000
Q4 2022

Feb 13, 2023

SELL
$39.19 - $65.67 $24,885 - $41,700
-635 Reduced 20.59%
2,449 $99,000
Q3 2022

Nov 14, 2022

SELL
$61.1 - $83.78 $195,703 - $268,347
-3,203 Reduced 50.95%
3,084 $202,000
Q2 2022

Aug 02, 2022

SELL
$43.23 - $73.83 $308,359 - $526,629
-7,133 Reduced 53.15%
6,287 $382,000
Q1 2022

May 23, 2022

BUY
$53.19 - $79.24 $56,860 - $84,707
1,069 Added 8.66%
13,420 $842,000
Q4 2021

Feb 14, 2022

SELL
$70.09 - $111.29 $30,489 - $48,411
-435 Reduced 3.4%
12,351 $936,000
Q3 2021

Nov 05, 2021

BUY
$110.2 - $156.64 $37,137 - $52,787
337 Added 2.71%
12,786 $1.43 Million
Q2 2021

Aug 12, 2021

BUY
$100.84 - $161.89 $231,024 - $370,889
2,291 Added 22.55%
12,449 $2.02 Million
Q1 2021

May 24, 2021

BUY
$110.72 - $210.04 $204,610 - $388,153
1,848 Added 22.24%
10,158 $1.24 Million
Q4 2020

Feb 09, 2021

BUY
$79.67 - $173.23 $571,154 - $1.24 Million
7,169 Added 628.31%
8,310 $1.27 Million
Q3 2020

Nov 16, 2020

BUY
$78.5 - $100.64 $89,568 - $114,830
1,141 New
1,141 $95,000
Q2 2020

Aug 10, 2020

SELL
$38.5 - $76.05 $25,949 - $51,257
-674 Closed
0 $0
Q4 2019

Feb 04, 2020

BUY
$36.68 - $73.13 $14,672 - $29,252
400 Added 145.99%
674 $41,000
Q2 2019

Aug 01, 2019

BUY
$35.45 - $48.2 $7,090 - $9,640
200 Added 270.27%
274 $0
Q2 2018

Jul 27, 2018

SELL
$42.62 - $73.59 $39,253 - $67,776
-921 Reduced 92.56%
74 $4,000
Q1 2018

Apr 23, 2018

BUY
$23.52 - $58.17 $23,402 - $57,879
995 New
995 $0
Q4 2017

Feb 08, 2018

SELL
$16.95 - $23.48 $1,695 - $2,348
-100 Closed
0 $0
Q2 2017

Aug 17, 2017

BUY
N/A
100
100 $2,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.16B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.